Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine followed by chemoradiation in pancreatic cancer: a randomized phase II trial.

Reni M, Balzano G, Aprile G, Cereda S, Passoni P, Zerbi A, Tronconi MC, Milandri C, Saletti P, Rognone A, Fugazza C, Magli A, Di Muzio N, Di Carlo V, Villa E.

Ann Surg Oncol. 2012 Jul;19(7):2256-63. doi: 10.1245/s10434-011-2205-2. Epub 2012 Jan 12.

PMID:
22237835
[PubMed - indexed for MEDLINE]
2.

PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: the ghost regimen.

Reni M, Cereda S, Galli L.

Cancer Lett. 2007 Oct 18;256(1):25-8. Epub 2007 Jun 11. Review.

PMID:
17561341
[PubMed - indexed for MEDLINE]
3.

Cisplatin alone or combined with gemcitabine in carcinomas of unknown primary: results of the randomised GEFCAPI 02 trial.

Gross-Goupil M, Fourcade A, Blot E, Penel N, Négrier S, Culine S, Chaigneau L, Lesimple T, Priou F, Lortholary A, Kaminsky MC, Provencal J, Voog E, Bouzy J, Laplanche A, Fizazi K.

Eur J Cancer. 2012 Mar;48(5):721-7. doi: 10.1016/j.ejca.2012.01.011. Epub 2012 Feb 6. Review.

PMID:
22317952
[PubMed - indexed for MEDLINE]
4.

Evidence-based guidelines for adjuvant therapy for resected adenocarcinoma of the pancreas.

Iott MJ, Corsini MM, Miller RC.

Clin J Oncol Nurs. 2008 Aug;12(4):599-605. doi: 10.1188/08.CJON.599-605. Review.

PMID:
18676327
[PubMed - indexed for MEDLINE]
5.

[Gemcitabine-based combinations in inoperable pancreatic cancers].

Louvet C, André T, Artru P.

Bull Cancer. 2002 Aug;89 Spec No:S96-101. Review. French.

PMID:
12449038
[PubMed - indexed for MEDLINE]
6.

The evolution of adjuvant and neoadjuvant chemotherapy and radiation for advanced pancreatic cancer: from 5-fluorouracil to GTX.

Fogelman DR, Chen J, Chabot JA, Allendorf JD, Schrope BA, Ennis RD, Schreibman SM, Fine RL.

Surg Oncol Clin N Am. 2004 Oct;13(4):711-35, x. Review.

PMID:
15350944
[PubMed - indexed for MEDLINE]
7.

[Adjuvant treatment of pancreatic cancer].

Oettle H.

Zentralbl Chir. 2003 May;128(5):411-8. Review. German.

PMID:
12813641
[PubMed - indexed for MEDLINE]
8.

[Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].

André T, Balosso J.

J Chir (Paris). 1999 Dec;136(6):309-17. Review. French.

PMID:
10675820
[PubMed - indexed for MEDLINE]
9.

[Chemoradiation in pancreatic carcinoma].

Claude L, Mornex F.

Cancer Radiother. 2003 Aug;7(4):254-65. Review. French.

PMID:
12914858
[PubMed - indexed for MEDLINE]
10.

Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.

Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD.

Ann Surg Oncol. 2012 May;19(5):1644-62. doi: 10.1245/s10434-011-2110-8. Epub 2011 Oct 20. Review.

PMID:
22012027
[PubMed - indexed for MEDLINE]
11.

[Adenocarcinoma of the pancreas. Therapeutic strategies].

André T, Balosso J, Louvet C, Houry S, Vaillant JC, Touboul E, Lotz JP, de Gramont A, Izrael V.

Presse Med. 1998 Mar 21;27(11):539-45. Review. French.

PMID:
9767970
[PubMed - indexed for MEDLINE]
12.

Locally advanced pancreatic cancer.

Oikonomopoulos GM, Huber KE, Syrigos KN, Saif MW.

JOP. 2013 Mar 10;14(2):126-8. doi: 10.6092/1590-8577/1469. Review.

PMID:
23474552
[PubMed - indexed for MEDLINE]
Free Article
13.

Management of locally advanced adenocarcinoma of the pancreas.

Ryan DP, Willett CG.

Hematol Oncol Clin North Am. 2002 Feb;16(1):95-103. Review.

PMID:
12063831
[PubMed - indexed for MEDLINE]
14.

Pooled survival and response data from phase III randomized controlled trials for gemcitabine-based regimes in the treatment of advanced pancreatic cancer.

Arshad A, Al-Leswas D, Al-Taan O, Stephenson J, Metcalfe M, Steward WP, Dennison AR.

Am J Clin Oncol. 2013 Aug;36(4):411-4. doi: 10.1097/COC.0b013e3182124216. Review.

PMID:
21436672
[PubMed - indexed for MEDLINE]
15.

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis.

Liao WC, Chien KL, Lin YL, Wu MS, Lin JT, Wang HP, Tu YK.

Lancet Oncol. 2013 Oct;14(11):1095-103. doi: 10.1016/S1470-2045(13)70388-7. Epub 2013 Sep 12. Review.

PMID:
24035532
[PubMed - indexed for MEDLINE]
16.

Developments in the systemic therapy of pancreatic cancer.

el-Rayes BF, Shields AF, Vaitkevicius V, Philip PA.

Cancer Invest. 2003;21(1):73-86. Review.

PMID:
12643012
[PubMed - indexed for MEDLINE]
17.

[Chemotherapy for pancreatic cancer].

Sakata Y, Takemori H, Suzuki H.

Gan To Kagaku Ryoho. 1996 Oct;23(12):1647-50. Review. Japanese.

PMID:
8886035
[PubMed - indexed for MEDLINE]
18.

Treatment of advanced and metastatic pancreatic cancer.

Blaszkowsky L.

Front Biosci. 1998 Nov 1;3:E214-25. Review.

PMID:
9792894
[PubMed - indexed for MEDLINE]
19.

[Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].

Drudi F, Tassinari D, Giuliani J, Ridolfi C, Gianni L, Tamburini E, Fantini M, Santelmo C, Barzotti E, Lotti N, Ravaioli A.

Recenti Prog Med. 2013 Feb;104(2):80-5. doi: 10.1701/1241.13711. Review. Italian.

PMID:
23535964
[PubMed - indexed for MEDLINE]
20.

[Adjuvant concomitant chemotherapy in pancreatic cancer].

Turci D, Cariello A, De Giorgi U, Marangolo M.

Tumori. 1999 Jan-Feb;85(1 Suppl 1):S36-42. Review. Italian.

PMID:
10235079
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk